Dr. Mark D. Hurwitz
Claim this profileWestchester Medical Center
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
6 reported clinical trials
21 drugs studied
Affiliated Hospitals
Clinical Trials Mark D. Hurwitz is currently running
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
More about Mark D. Hurwitz
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark D. Hurwitz has experience with
- Flutamide
- External Beam Radiation Therapy
- Apalutamide
- Bicalutamide
- Buserelin
- Degarelix
Breakdown of trials Mark D. Hurwitz has run
Prostate Adenocarcinoma
Prostate Cancer
Brachydactyly-mental retardation syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark D. Hurwitz specialize in?
Mark D. Hurwitz focuses on Prostate Adenocarcinoma and Prostate Cancer. In particular, much of their work with Prostate Adenocarcinoma has involved treating patients, or patients who are undergoing treatment.
Is Mark D. Hurwitz currently recruiting for clinical trials?
Yes, Mark D. Hurwitz is currently recruiting for 3 clinical trials in Valhalla New York. If you're interested in participating, you should apply.
Are there any treatments that Mark D. Hurwitz has studied deeply?
Yes, Mark D. Hurwitz has studied treatments such as Flutamide, External Beam Radiation Therapy, Apalutamide.
What is the best way to schedule an appointment with Mark D. Hurwitz?
Apply for one of the trials that Mark D. Hurwitz is conducting.
What is the office address of Mark D. Hurwitz?
The office of Mark D. Hurwitz is located at: Westchester Medical Center, Valhalla, New York 10595 United States. This is the address for their practice at the Westchester Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.